Denied reports of a Ford-Xiaomi partnership highlight a critical challenge for Western automakers struggling to compete with cost-effective Chinese EVs. This dynamic creates investment opportunities in the essential EV technology suppliers, such as semiconductor and battery firms, that power the industry's evolution.
Published on February 1
As Western automakers scramble to compete with Chinese EV technology, the demand for cutting-edge batteries, chips, and components is reaching fever pitch.
These companies provide the fundamental building blocks that power all electric vehicles, making them potentially less vulnerable to individual brand performance.
The global shift to electric vehicles creates massive opportunities for the suppliers that enable this transition, regardless of which automakers ultimately win.
The intense competition between Western automakers and Chinese EV manufacturers is creating unprecedented demand for the core technologies that power all electric vehicles. Rather than picking winners in the automotive race, we're focusing on the essential suppliers that benefit regardless of which brands succeed.
This collection spans the critical EV supply chain from lithium producers and battery manufacturers to semiconductor companies and powertrain specialists. These firms provide the fundamental building blocks that enable modern electric vehicles, making them potentially less vulnerable to individual automaker performance.
Each company was selected for its essential role in the EV ecosystem. As the industry accelerates its technological arms race, these suppliers of batteries, chips, and key components are positioned to benefit from the entire sector's growth, not just individual manufacturer success.
This basket's total market capitalisation is 5,233,217.11. It is heavily concentrated in one very large constituent, producing a pronounced large‑cap bias.
NVDA: $4.64T
ALB: $20.08B
QCOM: $161.91B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+2
Here are a few of the assets in this group. Create an account to unlock the full list.
On average, analysts expect assets in this group to grow 15.46% over the next year.
9 of 12 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitiv Ltd.
If you invested across these assets:
In 12 months it might be worth:
+15.46%
